"Tuberculosis and HIV Infection"

Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

"Tuberculosis and HIV Infection"

New England Journal of Medicine (12/26/91) Vol. 325, No. 26, P. 1883
Cathebras, P.J.

Abstract: The hypothesis that M. tuberculosis accelerates HIV infection should be further investigated, writes P.J. Cathebras of the Institute of Community and Family Psychiatry, Montreal, Canada. In the June 6 issue of the New England Journal of Medicine, Barnes et al. are reluctant to address the relationship between tuberculosis and HIV infection in developing countries, especially in sub-Saharan Africa. In a 1987-1988 survey in Bangui, Central African Republic, the seroprevalence of HIV among patients with newly diagnosed tuberculosis was 31 percent, compared to 8 percent in the general adult population. Antituberculosis drugs should be provided in primary care settings, as tuberculosis is the most common treatable disease associated with HIV infection. In addition, the high prevalence of both HIV infection and tuberculosis make it unadvisable to administer isoniazid chemoprophylazis to patients infected with both diseases because it could result in isoniazid-resistant organisms, the researchers conlude.

911226
AD910008

Copyright © 1991 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.